Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gossamer Bio Inc.

1.18
+0.05004.42%
Volume:1.63M
Turnover:1.96M
Market Cap:267.39M
PE:-3.72
High:1.29
Open:1.15
Low:1.13
Close:1.13
Loading ...

With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners

Simply Wall St.
·
03 Mar

Gossamer Bio Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
28 Feb

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Feb

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
08 Feb

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Business Wire
·
03 Feb

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

Simply Wall St.
·
30 Jan

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
30 Jan

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Business Wire
·
28 Jan

BRIEF-Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
08 Jan

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 Jan

Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media?

Insider Monkey
·
07 Jan

Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know

Zacks
·
27 Dec 2024

US Penny Stocks: 3 Picks With Market Caps Under $200M

Simply Wall St.
·
03 Dec 2024

All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy

Zacks
·
22 Nov 2024

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

Zacks
·
14 Nov 2024

BUZZ-Cautious uptake of Merck's Winrevair gives opportunity to rivals, Oppenheimer says

Reuters
·
14 Nov 2024